Redenlab Inc is a neuroscience technology company that uses speech and language biometrics to enhance decision making in clinical trials. We service in-clinic, in-home or virtual trials. Our cognitive-linguistic tests are valid, quick and reliable, with demonstrated sensitivity to subtle disease or treatment induced change. Speech software and hardware solutions capable of meeting regulatory requirements for security and integrity of data in clinical trials, including 21 CFR Part 11 and HIPAA.